Deutsche Bank AG increased its stake in Genpact Limited (NYSE:G - Free Report) by 485.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,110 shares of the business services provider's stock after acquiring an additional 11,700 shares during the period. Deutsche Bank AG's holdings in Genpact were worth $606,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of G. Coppell Advisory Solutions LLC lifted its stake in Genpact by 529.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after acquiring an additional 503 shares during the last quarter. SRH Advisors LLC acquired a new stake in shares of Genpact in the 4th quarter valued at $26,000. Atlas Capital Advisors Inc. lifted its position in shares of Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the last quarter. Manchester Capital Management LLC purchased a new stake in shares of Genpact during the 4th quarter worth $38,000. Finally, GeoWealth Management LLC grew its stake in shares of Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after purchasing an additional 583 shares in the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.
Genpact Stock Performance
NYSE G traded down $0.44 during trading hours on Friday, hitting $43.02. The company had a trading volume of 1,981,528 shares, compared to its average volume of 1,375,036. The business has a 50 day moving average of $46.76 and a 200-day moving average of $47.29. The company has a market cap of $7.52 billion, a PE ratio of 15.15, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. Genpact Limited has a 1-year low of $30.38 and a 1-year high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The firm had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The business's revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.73 EPS. As a group, equities research analysts expect that Genpact Limited will post 3.21 EPS for the current year.
Insider Activity
In related news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, with a total value of $87,940.00. Following the purchase, the director now owns 2,000 shares in the company, valued at $87,940. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 2.80% of the company's stock.
Analysts Set New Price Targets
A number of analysts have weighed in on G shares. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Needham & Company LLC cut their target price on Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a research report on Thursday, May 8th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Robert W. Baird lowered their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $50.71.
Check Out Our Latest Analysis on Genpact
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.